Acute muscle weakness - Differential diagnosis of neuromuscular diseases and their treatment;Akute Muskelschwache - Differentialdiagnose neuromuskularer Erkrankungen und ihre Behandlung

Intensivmedizin und Notfallmedizin

Volumn 34, Issue 2, 1997, Pages 110-123

  Mullges W ^a   Toyka, K V ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

chronic inflammatory demyelinating polyneuritis; Guillain Barre syndrome; Lambert Eaton syndrome; myasthenia gravis; neuromuscular diseases; poly dermatomyositis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN G; METHYLPREDNISOLONE;

CRITICAL ILLNESS; DERMATOMYOSITIS; DIFFERENTIAL DIAGNOSIS; EATON LAMBERT SYNDROME; GUILLAIN BARRE SYNDROME; HUMAN; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; NEURITIS; NEUROMUSCULAR DISEASE; PLASMAPHERESIS; POLYMYOSITIS; REVIEW;

EID: 0030864881     PISSN: 01753851     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003900050027     Document Type: Review

References (107)

1. Albers JW, Kelly JJ (1989) Aquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve 12:435-451
2. Al Janadi M, Smith CD, Karsh J (1989) Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis/dermatomyositis. J Rheumatol 16:1592-1596
3. Arsura EL, Brunner NG, Namba T, Grob D (1985) High-dose methylpredmsolone in myasthenia gravis. Arch Neurol 42:1149-1153
4. Arsura EL (1989) Experience with intravenous immunoglobulin in myasthenia gravis. Clin Immunol Immunopathol 53:170-179
5. Asbury AK, Cornblath DR (1990) Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 27:521-24
6. Asura EL, Greenberg AS (1988) Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatomyositis. Semin Arthr Rheum 18:29-37
7. Baier S, Schomaker MZ (1989) Bed number ten. CRC Press, Boca Raton
8. Barohn RJ, Kissel JT, Warmolts JR, Mendell JR (1989) Chronic inflammatory demyelinating polyradiculoneuropathy. Arch Neurol 46:878-884
9. Besinger UA, Toyka KV, Hömberg M, Heininger K, Hohlfeld R, Fateh-Moghadam A (1983) Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease activity. Neurology 33:1316-1323
10. Blanco K, Cuomo N (1983) From the other side of the bedrail: a personal experience with Guillain-Barré syndrome. J Neurosurg Nurs 15:355-359
11. Bolton CF, Laverty DA, Brown JD (1986) Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barré syndrome. J Neurol Neurosurg Psychiatr 49:563-573
12. Bowes D (1984) The doctor as a patient: an encounter with Guillain-Barré syndrome. Can Med Assoc J 131:1343-1348
13. Bril V, Ilse WK, Pearce R. Dhanani A, Sutton D, Kong K (1996) Pilot trial of immunoglobulin versus plasma exchange in patients with Guillain Barré syndrome. Neurology 46:100-103
14. Bunch TW (1990) Polymyositis. A case history approach to the differential diagnosis and treatment. Mayo Clin Proc 65:1480-1497
15. Cassem NH, Barsky AJ (1990) Functional somatic symptoms and somato-form disorders. In: Cassem NH (ed) Massachusetts General Hospital handbook of General Hospital psychiatry. Mosby, St. Louis, pp 131-157
16. Chalk CH, Murray NMF, O'Neill JH, Spiro SG (1990) Response of the Lambert-Eaton myasthenic syndrome to treatment of associated small-cell luna carcinoma. Neurology 40:1552-1556
17. Cherin P, Herson S (1994) Indications for intravenous gammaglobulin therapy in inflammatory myopathies. J Neurol Neurosurg Psychiatr 57:S50-54
18. Dalakas MC (1991) Polymyositis, dermatomyositis, and inclusion body myositis. New Engl J Med 325:1487-1498
19. Dalakas MC (1992) Inflammatory and toxic myopathies. Curr Opin Neurol Neurosurg 5:645-654
20. Dalakas MC (1995) Immunopathogenesis of inflammatory myopathies. Ann Neurol 37:S74-86
21. Dau PC (1992) Plasma exchange in polymyositis and dermatomyositis. N Engl J Med 327:1030
22. Downs JB, Klein EF, Desautels D, Modell JH, Kirby RR (1973) Intermittent mandatory ventilation: a new approach to wean patients from mechanical ventilators. Chest 64:331-335
23. Drachman DB (1994) Myasthenia gravis. N Engl Med J 331:1797-1807
24. Dutch Guillain-Barré syndrome Study Group (1994) Treatment of Guillain-Barré syndrome with high-dose immune globulins combined with methylprednisolone: a pilot study. Ann Neurol 35:749-752
25. Dyck PJ, O'Brien PC, Oviatt KF (1982) Prednisone improves chronic inflammatory demyelinating polyneuropathy more than no treatment. Ann Neurol 11:136-141
26. Dyck PJ, Daube J, O'Brien P (1986) Plasma exchange in chronic inflammatory demyelinating polyneuropathy. N Engl J Med 314:461-465
27. Eidelberg D, Sotrel A, Vogel H (1986) Progressive polyradiculopathy in aquired immune deficiency syndrome. Neurology 36:912-916
28. Ewing DJ (1992) Analysis of heart rate variability and other non-invasive tests with special reference to diabetes mellitus. In: Bannister R, Mathias CJ (eds) Autonomic failure. Oxford University Press, Oxford, pp 312-333
29. Flachenecker P, Müllges W, Wermuth P, Hartung HP, Reiners K (1996) Eye-ball pressure testing may indicate serious bradyarrythmias in Guillain-Barré syndrome. Neurology 47:102-108
30. Gajdos PH, Myasthenia gravis Clinical Study Group (1993) A randomized trial comparing prednisolone and azathioprine in myasthenia gravis. J Neurol Neurosurg Psychiatr 56:1157-1163
31. Gibbels E, Giebisch U (1992) Natural course of acute and chronic monophasic inflammatory demyelinating polyneuropathies. Acta Neurol Scand 85:282-291
32. Griggs RC, Donahue KM, Utell MJ, Goldblatt D, Moxley RT (1981) Evaluation of pulmonary function in neuromuscular disease. Arch Neurol 38:9-12
33. Gold R, Hartung HP (1993) Therapie von Immunneuropathien. Akt Neurol 20: 147-160
34. Gold R, Hartung HP, Toyka KV (1995) Therapie mit Immunglobulineri bei neurologischen Autoimmunerkrankunsen. Fortschr Neurol Psychiatr 63:17-29
35. Grob D, Simpson D, Mitsumoto H, Hoch B, Makhtarian F, Bender A, Greenberg M, Koo A, Nakayama S (1995) Treatment of myasthenia gravis by immunoadsorption of plasma. Neurology 45:338-344
36. Guillain-Barré Syndrome Study Group (1985) Plasmapheresis and acute Guillain-Barré syndrome. Neurology 35:1096-1104
37. Guillain-Barré Syndrome Steroid Trial Group (1993) Double-blind trial of intravenous methylprednisolone in Guillain-Barré syndrome. Lancet 341:586-590
38. Gutmann L, Blumenthal D, Gutmann L, Schochet SS (1996) Acute type II myofiber atrophy in critical illness. Neurology 46:819-821
39. Haerer AF (1992) De Jong's The neurologic examination. Examination in cases of suspected hysteria and malingering. 5th ed. Lippincott. Philadelphia, pp 733-751
40. Hartung HP, Pollard JD, Harvey GK, Toyka KV (1995) Immunopathogenesis and treatment of the Guillain-Barré syndrome. Part I and II. Muscle Nerve 18:137-164
41. Heininger K, Hendricks M, Toyka KV (1985) Myasthenia gravis: a new semiselective procedure to remove acetylcholine receptor autoantibodies from plasma. Plasma Ther 6:771-775
42. Hirano M, Ott BR, Raps EC (1992) Acute quadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents or both. Neurology 42:2082-2087
43. Hohlfeld R, Michels M, Heininger K, Besinger UA, Toyka KV (1988) Azathioprine toxicity during long-term immunosuppression of generalized myasthenia aravis. Neurology 38:258-261
44. Kohlfeld R, Toyka KV (1993) Therapies in myasthenia gravis. In: DeBaets NH, Oosterhuis HJGH (Hrsg.) Myasthenia gravis. CRC Press, Boca Raton: 235-261
45. Hughes RAC, Newsom-Davis JM, Perkin GD, Pierce JM (1978) Controlled trial of prednisolone in acute polyneuropathy. Lancet 2:750-753
46. Hughes RAC (1990) Guillain-Barré syndrome. Springer, London
47. Hughes RAC, Bihari D (1993) Acute neuromuscular respiratory paralysis. J Neurol Neurosurg Psychiatr 56:334-343
48. Hughes RAC, Swan A (1995) Treatment of Guillain-Barré syndrome with intravenous methylprednisolone. Ann Neurol 37:683
49. Hund EF, Hartung HP, Ropper AH (1994) Chronic inflammatory demyelinating polyneuropathy. In: Hacke W (Hrsg.) Neurocritical Care. Springer, Berlin-Heidelberg: 788-795
50. Jerusalem F (1987) Entzündliche Muskelerkrankunsen. Internist 28:580-588
51. Jerusalem F, Zierz S (1991) Polymyositis und Dermatomyositis. In: Jerusalem F. Zierz S (Hrsg) Muskelerkrankungen. 2. Aufl., Thieme, Stuttgart, Berlin, S 254-269
52. Kahan BD (1989) Cyclosporine. N Engl J Med 321:1725-1738
53. Kelly BJ, Luce JM (1991) The diagnosis and management of neuromuscular diseases causing respiratory failure. Chest 99:1485-1494
54. Kleyweg RP, van der Meché FGA, Loonen MCB, De Jong J, Knip B (1989) The natural history of the Guillain-Barré syndrome in 18 children and 50 adults. J Neurol Neurosurg Psychiatr 52:853-856
55. Krendel DA, Parks HP, Antony DC, StClair MB, Graham DG (1989) Sural nerve biopsy in chronic inflammatory demyelinating polyradiculopathy. Muscle Nerve 12:257-264
56. Lang B, Newsom-Davis J, Wray D, Murray N (1981) Autoimmune etiology for myasthenic (Lambert-Eaton) syndrome. Lancet 2:224-226
57. Laroche CM, Mier AK, Spiro SG, Newsom-Davis J, Moxham J, Green M (1984) Respiratory muscle weakness in the Lambert-Eaton myasthenic syndrome. Thorax 44:913-918
58. Lehmann-Horn F, Rüdel R (1995) Hereditary nondystrophic myotonias and periodic paralyses. Curr Opin Neurol 8:402-410
59. Lennon VA, Kryzer TJ, Griesmann GE, Padraig MS, O'Suillebhain E, Windebank AJ, Woppmann A, Miljanich GP, Lambert EH (1995) Calcium channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. New Engl J Med 332:1467-1474
60. Mastaglia FL (1982) Adverse effects of drugs on muscle. Drugs 24:304-321
61. McCombe, Pollard JD, McLeod (1987) Chronic inflammatory demyelinating polyradiculo-neuropathy. Brain 110:617-1630
62. McEvoy KM, Windebank AJ, Daube JR, Low PA (1989) 3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome. New Engl J Med 321:1567-1571
63. McLeod JG (1992) Autonomic dysfunction in peripheral nerve disease. In: Bannister R, Mathias CJ (eds) Autonomic failure. Oxford University Press, Oxford, pp 659-681
64. Müllges W, Naumann M, Reichmann H (1993) Wird die chronische Dermato- oder Polymyositis als "Altersschwäche" verkannt? Deutsch Med WoSchri 118:1520-1524
65. Nemni R, Amadio S, Fazio R, Galardi G, Previtali S, Comi G (1994) Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating neuropathy not responsive to other treatments. J Neurol Neurosurg Psychiatr 57:S43-45
66. Newsom-Davis J, Leys K, Vincent A, Ferguson I, Modi G, Mills K (1991) Immunological evidence for the coexistence of the Lambert-Eaton myasthenic syndrome and myasthenia gravis in two patients. J Neurol Neurosurg Psychiatr 54:452-453
67. NIH Consensus Development Conference (1990) Intravenous immunoglobulins. JAMA 264:3189-3193
68. O'Neill JH, Murray NMF, Newsom-Davis J (1988) The Lambert-Eaton myasthenic syndrome. Brain 111:577-596
69. Oosterhuis HJGH (1993) Myasthenia gravis. Clinical aspects In: DeBaets NH, Oosterhuis HJGH (eds) Myasthenia gravis. CRC Press, Boca Raton, pp 14-42
70. Parker H (1984) Communication breakdown. Nursing Mirror 158:37-39
71. Pentland B, Donald SM (1994) Pain in the Guillain-Barré syndrome. Pain 59:159-164
72. Perez MC, Buot WL, Mercado-Danguilan C, Bagabaldo ZG, Renales LD (1981) Stable remissions in myasthenia gravis. Neurology 31:32-38
73. Pollard JD (1987) A critical review of therapies in acute and chronic inflammatory demyelinating polneuropathies. Muscle Nerve 10:214-221
74. Rice D (1977) Landry-Guillain-Barré syndrome. Personal experience of acute ascending paralysis Brit Med J 1:1330-1332
75. Rich MM, Teener JW, Raps EC, Schotland DL, Bird SJ (1996) Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology 46:731-736
76. Ricker K, Rohkamm R, Böhlen R (1986) Adynamia episodica and paralysis periodica paramyotonica. Neurology 36:682-686
77. Rieke K, Kuncl RW (1994) Rhabdomyolysis and acute presentations of myopathies. In: Hacke W (eds) Neurocritical Care. Springer. Berlin-Heidelberg, pp 822-826
78. Riggs JE, Griggs R, Moxley RT (1984) Dissociation of glucose and potassium arterial-venous differences across the forearm by acetazolamide. Arch Neurol 41:35-38
79. Ropper AH (1988) ICU management of acute inflammatory-postinfectious polyneuropathy. In: Ropper AH, Kennedy SH (Hrsg.) Neurological and neurosurgical critical care. Rockville, Aspen: 253-268
80. Ropper AH, Wijdicks EFM, Truax BT (1991) Guillain-Barré syndrome. FA Davis, Philadelphia
81. Ropper AH (1992) Current concepts: the Guillain Barré syndrome. New Engl J Med 326:1130-1136
82. Sanders DB (1995) Lambert-Eaton myasthenic syndrome: clinical diagnosis, immune-mediated mechanisms, and update of therapies. Ann Neurol 37:S63-73
83. Schmidt B, Toyka KV, Kiefer R, Full J, Hartung HP, Pollard J (1996) Inflammatory infiltrates in sural nerve biopsies in Guillain-Barré syndrome and chronic inflammatory demyelinatine neuropathy. Muscle Nerve 19:474-87
84. Schmidt-Degenhard M (1986) Oneiroides Erleben bei intensivbehandelten panplegischen Polyradikulitis-Patienten. Nervenarzt 57:712-718
85. Shearn MA, Shearn L (1986) A personal experience with Guillain-Barré syndrome, are the psychologic needs of patient and family being met? South Med J 79:800-803
86. Smith AG, Wald J (1996) Acute ventilatory failure in Lambert-Eaton myasthenic syndrome and its response to 3,4-diaminopyridine. Neurology 46:1143-1145
87. So YT, Olney RK (1994) Acute lumbosacral polyradiculopathy in aquired immunodeficiency syndrome: Experience in 23 patients. Ann Neurol 35:53-58
88. Thornton CA, Griggs RC (1994) Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease Ann Neurol 35:260-268
89. Tindall RSA, Rollins JA, Phillips JT, Greenlee RG, Wells L, Belendiuk G (1987) Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine A in myasthenia gravis. N Engl J Med 316:719-723
90. Toyka KV, Augspach R, Wiethölter H, Besinger UA, Haneveld F, Liebert UG, Heininger K, Schwendemann G, Reiners K, Grabensee B (1982) Plasma exchange in chronic inflammatory polyneuropathy: evidence suggestive of a pathogenic humoral factor. Muscle Nerve 5:479-484
91. Toyka KV, Heininger K (1987) Humoral factors in peripheral nerve disease. Muscle Nerve 10:222-232
92. Toyka KV, Hartung HP (1993) Circulating immune factors. In: Asbury AK, McKhann GM, McDonald WI (eds) Diseases of the nervous system. WB Saunders, Philadelphia, 2 ed, pp 1396-1309
93. Tuck RR, McLeod JG (1982) Autonomic dysfunction in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatr 44:983-990
94. Uprichard E, Martin A, Evans S (1987) Guillain-Barré syndrome: patients' and nurses perspective. Intensive Care Nursing 2:123-134
95. van der Meché FGA, Schmitz PI, Dutch GBS Study Group (1992) A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré-syndrome. N Engl J Med 326:1123-1129
96. van der Meché FGA (1994) The Guillain-Barré syndrome: plasma exchange or immunoglobulins intravenously. J Neurol Neurosurg Psychiatr 57:S33-34
97. van Doom PA, Vermeulen M, Brand A (1991) Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy. Arch Neurol 48:217-220
98. Vermeulen M, van der Meché FGA, Speelman JD (1993) Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatr 56:36-39
99. Voltz R, Rosen FV, Yousry T, Beck J, Hohlfeld R (1996) Reversible encephalopathy with cerebral vasospasm in a Guillain-Barré syndrome patient treated with intravenous immunoglobulin. Neurology 46:250-251
100. Weiß H (1991) Psychische Veränderungen bei intensivbehandelten Patienten mit akutem Guillain-Barré-Syndrom. Fortschr Neurol Psychiatr 59:134-140
101. Wieling W (1992) Non-invasive continuous recording of heart rate and blood pressure in the evaluation of neurocardiovascular control. In: Bannister R, Mathias CJ (eds) Autonomic failure. Oxford University Press, Oxford, pp 291-311
102. Wijdicks EFM (1995) Neurology of critical illness. FA Davis, Philadelphia: 74-77
103. Winer JB, Hughes RAC, Osmond C (1988) A prospective study of acute idiopathic neuropathy. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatr 51:605-612
104. Witt NJ, Zochodne DW, Bolton CF (1991) Peripheral nerve function in sepsis and multiple organ failure. Chest 99:176-184
105. Zifko U, Chen R, Remtulla H, Hahn AF, Koopmann W, Bolton CF (1996) Respiratory electrophysiological studies in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatr 60:191-194
106. Zochodne DW, Bolton CF, Wells GA (1987) Critical illness polyneuropathy: a complication of critical illness and multiple organ failure Brain 110:819-841
107. Zochodne DW, Ramsay DA, Shelley S, Moffat S (1994) Acute necrotizing myopathy of intensive care: electrophysiological studies. Muscle Nerve 17:285-292